SCHEMBL6208499

SCHEMBL6208499

COc1ccc(-c2nc(Cl)oc2-c2ccc(OCc3ccccc3)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.56
ALDH1A1 P00352 2/20 0.56
LMNA P02545 2/20 0.56
HTT P42858 1/20 0.56
PPARD Q03181 4/20 0.46
ENPP3 O14638 1/20 0.45
ENPP1 P22413 1/20 0.45
MAPT P10636 3/20 0.45
IKBKE Q14164 1/20 0.44
FAAH O00519 1/20 0.44
MGLL Q99685 1/20 0.44
ANO1 Q5XXA6 1/20 0.44
MEN1 O00255 1/20 0.43
BCHE P06276 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
CYP19A1 P11511 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11748988 0.87 ALDH1A1 (0.55) NPSR1ALDH1A1LMNAHTTPPARD
SCHEMBL11755271 0.87 ALDH1A1 (0.55) NPSR1ALDH1A1LMNAHTTPPARD
SCHEMBL6207736 0.86 NPSR1 (0.54) NPSR1ALDH1A1LMNAHTTPPARD
SCHEMBL3105040 0.84 ALDH1A1 (0.45) NPSR1ALDH1A1LMNAPPARDMAPT
SCHEMBL6539039 0.83 NPSR1 (0.54) NPSR1ALDH1A1LMNAHTTPPARD
SCHEMBL6539583 0.83 NPSR1 (0.51) NPSR1ALDH1A1LMNAHTTPPARD
SCHEMBL6540399 0.83 PPARD (0.54) NPSR1ALDH1A1LMNAHTTPPARD
SCHEMBL6231803 0.83 PPARD (0.54) NPSR1ALDH1A1LMNAHTTPPARD
SCHEMBL6538937 0.83 NPSR1 (0.51) NPSR1ALDH1A1LMNAHTTPPARD
SCHEMBL6229619 0.82 NR4A2 (0.58) NPSR1ALDH1A1LMNAHTTPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583749-A1 OXAZOLE DERIVATIVES AS INHIBITORS OF CYCLOOXYGENASE Astellas Pharma Inc. (JP) 2005-10-12 EP disclosed
US-20040157891-A1 Inhibitor of cox FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed
WO-2004065374-A1 OXAZOLE DERIVATIVES AS INHIBITORS OF CYCLOOXYGENASE ASTELLAS PHARMA INC. (JP) 2004-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157891-A1 Inhibitor of cox PTGS1, PTGS2, PTGES2 NPSR1 884/4885ALDH1A1 163/4885LMNA 2620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.